`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`TWI PHARMACEUTICALS, INC.,
`Petitioner,
`
`V.
`
`MERCK SERONOSA,
`Patent Owner.
`
`Case IPR2023-00049
`U.S. Patent No. 7,713,947
`
`Case IPR2023-00050
`U.S. Patent No. 8,377,903
`
`MERCK SERONO SA POWEROF ATTORNEY
`UNDER37 C.E.LR. §42.10
`
`
`
`Patent Owner Merck Serono SA hereby appoints the following attorneys
`
`and/or agents to prosecute the above captioned inter partes reviews andto transact
`
`all business in the U.S. Patent and Trademark Office connected herewith:
`
`e All practitioners at Customer Number 23483
`
`e All attorneys at Wilmer Cutler Pickering Hale and Dorr LLP for whom a
`
`motion to appear pro hacviceis filed
`
`Please address all communicationsto:
`
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State Street
`Boston, MA 02109
`Telephone: 617-526-6000
`Facsimile: 617-526-5000
`
`Please addressall e-mails and telephonecalls to lead andback-up counsel,
`
`each of whomare listed above orassociated with the above Customer Number, and
`
`are listed below:
`
`e Lead Counsel
`
`Emily R. Whelan, Reg. No. 50,391
`Emily.Whelan@wilmerhale.com
`Telephone: 617-526-6567
`
`e First Back-up Counsel:
`
`Deric Geng, Reg. No. 73,434
`Deric.Geng@wilmerhale.com
`Telephone: 617-526-6026
`
`e Second Back-up Counsel:
`
`
`
`Senior Director, Associate General Patent Counsel
`
`Director, Corporate Patent Counsel
`
`